Leading Players in Thailand Pregabalin Market | Competitive Landscape 2026

Thailand Pregabalin Market Overview

According to 6Wresearch, the Thailand pregabalin market is witnessing strong growth due to rising prevalence of neuropathic pain, diabetic neuropathy, and fibromyalgia. Increasing awareness of neurological disorders and higher adoption of prescription therapeutics are key drivers. The market is further boosted by hospital expansions, increasing private healthcare accessibility, and the growing trend of generic adoption for cost-effective therapies.

Competitive Landscape

The competitive landscape of the pregabalin market in Thailand is a mix of global pharmaceutical majors and regional manufacturers. These companies ensure market diversity by offering both branded and generic pregabalin formulations addressing chronic pain, epilepsy, and anxiety disorders.

Leading Players Operating in the Thailand Pregabalin Market:

1. Pfizer Inc.

A global pioneer in neuropathic pharmacology, Pfizer provides the foundational clinical research and high-efficacy standards that currently define the gold standard for pregabalin therapy.

2. Viatris Inc.

A major force in the global access space, Viatris focuses on multi-regional supply chain reliability and patient-focused outcomes for long-term chronic pain management.

3. Sun Pharmaceutical Industries Limited

A historic innovator in complex generic manufacturing, Sun Pharma is renowned for its vertical integration and precision in delivering high-volume, cost-effective neurological medications.

4. Teva Pharmaceutical Industries Ltd.

A global leader in the neurology segment, Teva integrates robust R&D with vast manufacturing capabilities to offer specialized treatments that cater to varied patient metabolic requirements.

5. Novartis AG

Caters to the modern clinical landscape with a focus on evidence-based efficacy and safety profiles that emphasize transparency in patient outcomes and ease of use for medical practitioners.

6. Sandoz Group AG

Combines hardware-grade pharmaceutical excellence with sustainable distribution, offering stable supply chains for essential pain management medicines in a single, reliable channel.

7. Glenmark Pharmaceuticals Limited

A research-led organization that leverages cutting-edge formulation technology to provide high-precision treatments for chronic pain and neurological disorders across diverse markets.

8. Torrent Pharmaceuticals Limited

Part of the global life-science ecosystem, this brand focuses on providing highly customizable therapeutic options integrated with advanced quality-control protocols.

9. Zydus Lifesciences Limited

Leverages decades of global experience to provide technology-enabled pharmaceutical administration services tailored for the Southeast Asian corporate and hospital sectors.

10. Lupin Limited

Delivers high-quality neurological medicine platforms that emphasize patient recovery and adherence, leveraging state-of-the-art synthetic capabilities.

11. Dr. Reddy’s Laboratories Limited

Focuses on affordable, high-precision pharmacological solutions, utilizing digital integration to track patient data and medication efficacy.